Organon & Co | OGN - DEBITO





DEBITO Cambiamento Data
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Celltrion KRW 160.58B 733.3M 2026-03
Cspc Pharmaceutical CNY 641.11M 146.11M 2025-12
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.36M 79K 2026-03
Divis Laboratories Ltd INR 70M 30M 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
Glaxosmithkline GBP 19.06B 1.31B 2026-03
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Merck USD 49.12B 222M 2026-03
Neuren Pharmaceuticals AUD 0 0 2024-12
Novartis USD 47B 14.98B 2026-03
Organigram Holdings CAD 8.2M 554K 2026-03
Organon & Co USD 8.55B 16M 2026-06
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 45.84M 1.7M 2026-06
Qiagen NV USD 1.65B 165.82M 2026-03
Sartorius EUR 4.05B 248.8M 2026-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Tilray USD 640.95M 35.17M 2022-06
Zealand Pharma A/S 414M 8.23M 2026-03